AU2001283085A1 - Synergistic effect of amlodipine and atorvastatin - Google Patents

Synergistic effect of amlodipine and atorvastatin

Info

Publication number
AU2001283085A1
AU2001283085A1 AU2001283085A AU8308501A AU2001283085A1 AU 2001283085 A1 AU2001283085 A1 AU 2001283085A1 AU 2001283085 A AU2001283085 A AU 2001283085A AU 8308501 A AU8308501 A AU 8308501A AU 2001283085 A1 AU2001283085 A1 AU 2001283085A1
Authority
AU
Australia
Prior art keywords
amlodipine
atorvastatin
synergistic effect
synergistic
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283085A
Inventor
R. Preston Mason
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001283085A1 publication Critical patent/AU2001283085A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
AU2001283085A 2000-08-04 2001-08-03 Synergistic effect of amlodipine and atorvastatin Abandoned AU2001283085A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22321400P 2000-08-04 2000-08-04
US60223214 2000-08-04
PCT/US2001/024209 WO2002011723A1 (en) 2000-08-04 2001-08-03 Synergistic effect of amlodipine and atorvastatin

Publications (1)

Publication Number Publication Date
AU2001283085A1 true AU2001283085A1 (en) 2002-02-18

Family

ID=22835550

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283085A Abandoned AU2001283085A1 (en) 2000-08-04 2001-08-03 Synergistic effect of amlodipine and atorvastatin

Country Status (3)

Country Link
US (2) US6835742B2 (en)
AU (1) AU2001283085A1 (en)
WO (1) WO2002011723A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030324A1 (en) * 2001-07-31 2003-04-03 Warner Lambert Co PHARMACEUTICAL COMPOSITIONS OF AMLODIPINE AND ATORVASTATIN
WO2005097191A2 (en) * 2004-04-04 2005-10-20 Sepracor Inc. COMBINATIONS COMPRISING (S)- AMLODIPINE AND A HMG-CoA REDUCTASE INHIBITOR OR CHOLESTEROL ABSORPOTION INHIBITOR OR BOTH, AND METHODS FOR REDUCING HYPERTENSION
US20090042849A1 (en) * 2006-12-06 2009-02-12 Yochai Birnbaum Phosphorylation of 5-lipoxygenase at ser523 and uses thereof
CA2759176C (en) 2009-04-29 2016-03-15 Amarin Corporation Plc Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
KR102012111B1 (en) 2009-06-15 2019-08-19 아마린 파마, 인크. Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US20140127289A1 (en) 2010-11-29 2014-05-08 Armarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
MD4412C1 (en) * 2014-08-29 2016-11-30 Алёна ДУРНЯ Use of 4-({2-butyl-5-[2-carboxy-2-(thiophene-2-ylmethyl)et-1-en-1-yl]-1H-imidazole-1-yl}methyl)benzoic acid to improve vascular elasticity in the prevention of complications of hypertensive genesis
WO2020068163A1 (en) 2018-09-24 2020-04-02 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
GT199800127A (en) * 1997-08-29 2000-02-01 THERAPEUTIC COMBINATIONS.
US7129265B2 (en) * 1999-04-23 2006-10-31 Mason R Preston Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
HN2000000050A (en) * 1999-05-27 2001-02-02 Pfizer Prod Inc MUTUAL SALT OF AMLODIPINO AND ATORVASTATINA

Also Published As

Publication number Publication date
US20050009888A1 (en) 2005-01-13
US20020052394A1 (en) 2002-05-02
US6835742B2 (en) 2004-12-28
WO2002011723A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU9025701A (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containingthe same
AU3572599A (en) Analgesic compositions comprising nmda-antagonists and abt-594
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU2001225816A1 (en) Therapeutic combination of amlodipine and benazepril
AU2001280599A1 (en) Compounds and methods
HRP20040067A2 (en) Pharmaceutical compositions of amlodipine and atorvastatin
AU2001253418A1 (en) Compounds and methods
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001283085A1 (en) Synergistic effect of amlodipine and atorvastatin
AU2002220419A1 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AU2001243394A1 (en) Compounds and methods
HK1046282A1 (en) Mutual prodrugs of amlodipine and atorvastatin
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AUPQ872300A0 (en) Compounds and methods
AUPQ885500A0 (en) Enhancement of products
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU4432001A (en) Trityl-type compounds and their use
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
PL351408A1 (en) Synergistic effects of amlodipine and atorvastatin
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2002235277A1 (en) Compounds and methods
AU2001251370A1 (en) Antimicrobial methods and materials
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
ZA200108685B (en) Synergistic effects of amlodipine and atorvastatin.